Trials / Completed
CompletedNCT02214771
Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients
Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients (DAFNE Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 296 (actual)
- Sponsor
- Astellas Pharma S.A.S. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to describe the characteristics and the methods of management and follow-up of patients treated with fidaxomicin for Clostridium difficile infection (CDI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fidaxomicin | oral |
| DRUG | Treatment for CDI other than fidaxomicin Type | Oral |
Timeline
- Start date
- 2014-09-03
- Primary completion
- 2017-03-27
- Completion
- 2017-08-17
- First posted
- 2014-08-12
- Last updated
- 2017-10-12
Locations
24 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02214771. Inclusion in this directory is not an endorsement.